GCH1 can effectively rescue ferroptosis induced by ferroptosis inducers and GPX4 deletion, but not apoptosis and necrosis
has received research grants from AbbVie, AstraZeneca, CSL Behring, Eli Lilly, Esperion Therapeutics and Novartis, paid to his institution, and has served as a consultant for Akebia Therapeutics, Alnylam Pharmaceuticals, Ardelyx, Canary Cure, Eli Lilly, FibroGen, GlaxoSmithKline, Intarcia, Medtronic Vascular, the Novartis Pharmaceuticals Corporation, Novo Nordisk, Provention Bio, and ReCor Medical
intramuscular injection is not an emergency but should be reported so your next dose can be timed correctly to account for the faster absorption you just experienced
Clinical monitoring further enhances outcomes by identifying adjustments needed to maintain alignment with treatment goals
Recent Developments: 2025: Eli Lilly received FDA approval for tirzepatide (Zepbound) as a treatment for moderate-to-severe obstructive sleep apnea in adults with obesity the first pharmacotherapy approved for this indication expanding tirzepatide's approved uses beyond metabolic conditions into a respiratory indication affecting over 30 million Americans and supported by SURMOUNT-OSA trial data showing 63% reduction in apnea-hypopnea index
Pep tracks both injectable and oral GLP-1 medications, so it fits weekly shots like Ozempic, Wegovy, Mounjaro, and Zepbound as well as daily options like Rybelsus and the Wegovy pill